Suchergebnisse - "Itolizumab"

PubPharm (15)

1

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India : a retrospective cohort study

enthalten in: Acute and critical care | 2024

von Kumar, A. | Kumar, N. | Pattanayak, A. | +4

2

REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19 : a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT

enthalten in: Expert opinion on biological therapy | 2023

von Kr, R. | Rathod, C. | Darnule, R. | +8

3

Role of Itolizumab in the Treatment of COVID-19 Patients, Admitted to ICU at a Tertiary Care Hospital

enthalten in: The Journal of the Association of Physicians of India | 2022

von Kurri, N. | Tyagi, B. | Kaushik, A. | +3

4

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

5

Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis : A Small Case Series Using Streptokinase

enthalten in: Seminars in thrombosis and hemostasis | 2021

von Caballero López, A. | Herrera Cartaya, C. | Chávez González, E. | +8

6

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

7

An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome : report of three cases

enthalten in: Immunotherapy | 2021

von Filgueira, L. | Cervantes, J. | Lovelle, O. | +14

8

Itolizumab Treatment for Cytokine Release Syndrome in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19 : Clinical Outcomes, A Retrospective Study

enthalten in: The Journal of the Association of Physicians of India | 2021

von Gore, V. | Kshirsagar, D. | Bhat, S. | +2

9

Approval of Itolizumab for COVID-19 : A Premature Decision or Need of The Hour?

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2020

von Atal, S. | Fatima, Z. | Balakrishnan, S.

10

Possible treatment and strategies for COVID-19 : review and assessment

enthalten in: European review for medical and pharmacological sciences | 2020

von Trivedi, N. | Verma, A. | Kumar, D.